AKT1 mutations have been identified in 6–7% of oestrogen receptor-positive breast cancer metastases,3 and a more comprehensive biomarker analysis, including mutational status of all AKT isoforms, is underway on FAKTION samples. The gene discussed is AKT1; the disease is breast cancer.